Loading clinical trials...
Loading clinical trials...
National french registry of patients with tetralogy of Fallot and implantable cardioverter defibrillator.
Inclusion criteria: * patient with tetralogy of Fallot \> 18 years * implantable cardioverter defibrillator (ICD) * primary or secondary prevention All french centers performing ICD implantation are annually contacted to include all patients with tetralogy of Fallot and ICD. Retrospective inclusion of cases before 2010 and prospective inclusion after 2010 with prospective follow up and annual update. All events are centrally adjudicated with collection of all baseline ECG and reviewing of endocavitary EGM.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Paris Sudden Death Expertise Center
Paris, France
Start Date
December 1, 2010
Primary Completion Date
August 1, 2019
Completion Date
December 31, 2030
Last Updated
February 12, 2019
150
ESTIMATED participants
Lead Sponsor
Paris Sudden Death Expertise Center
NCT05647213
NCT07042334
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions